Clinical Trial Update: Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib [Phase 1]

View source ↗

Summary

Phase I study assessing weekly and every-3-week Abraxane in combination with Vandetanib for solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Vandetanib (vandetanib)

Snippet

Sponsor: University of Southern California | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED